Vitamin E: cautionary issues

Compared with many medications used in the patient with cardiovascular disease, vitamin E is a relatively safe supplement. There are a few populations in which caution needs to be employed, however. Patients receiving warfarin therapy should be discouraged from using vitamin E supplements and should...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current treatment options in cardiovascular medicine 2000-04, Vol.2 (2), p.1-3
1. Verfasser: Spencer, A P
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3
container_issue 2
container_start_page 1
container_title Current treatment options in cardiovascular medicine
container_volume 2
creator Spencer, A P
description Compared with many medications used in the patient with cardiovascular disease, vitamin E is a relatively safe supplement. There are a few populations in which caution needs to be employed, however. Patients receiving warfarin therapy should be discouraged from using vitamin E supplements and should be closely monitored if they do. Smokers should avoid vitamin E due to potential negative effects on vitamin C, and vitamin E should never be administered in conjunction with beta-carotene in this population. The rare patient requiring vitamin A therapy or having retinitis pigmentosa should also avoid vitamin E supplementation. Because of the increased risk of bleeding, vitamin E should be discontinued in the perioperative period in any patient requiring surgery.
doi_str_mv 10.1007/s11936-000-0001-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_755189011</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2920182169</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1736-303ba2c8ac95d346f0214c16f6665cacb5e0f9f8dbefeed93dabf5557a1620d3</originalsourceid><addsrcrecordid>eNpdUEtLxDAQDqK46-oPEEQKHjxVZ5ImTbzJsj5gwcviNaRpAl36WJv24L83pasHD8PM4XvM9xFyjfCAAPljQFRMpAAwDabihCyRsyxlKNVpvEHRVGYiW5CLEPYAlDMpz8mCgswk42JJbj6rwTRVm2yeEmvGoepa038nVQijC5fkzJs6uKvjXpHdy2a3fku3H6_v6-dtajGP_gxYYaiVxipeskx4oJhZFF4Iwa2xBXfglZdl4bxzpWKlKTznPDcoKJRsRe5n2UPffUXbQTdVsK6uTeu6Meic85gHECPy7h9y3419G3_TVFFASVGoiMIZZfsuhN55feirJsbSCHoqTs_F6VjaNKhF5NwelceiceUf47cp9gOsCGZx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2920182169</pqid></control><display><type>article</type><title>Vitamin E: cautionary issues</title><source>Springer Nature - Complete Springer Journals</source><source>ProQuest Central</source><creator>Spencer, A P</creator><creatorcontrib>Spencer, A P</creatorcontrib><description>Compared with many medications used in the patient with cardiovascular disease, vitamin E is a relatively safe supplement. There are a few populations in which caution needs to be employed, however. Patients receiving warfarin therapy should be discouraged from using vitamin E supplements and should be closely monitored if they do. Smokers should avoid vitamin E due to potential negative effects on vitamin C, and vitamin E should never be administered in conjunction with beta-carotene in this population. The rare patient requiring vitamin A therapy or having retinitis pigmentosa should also avoid vitamin E supplementation. Because of the increased risk of bleeding, vitamin E should be discontinued in the perioperative period in any patient requiring surgery.</description><identifier>ISSN: 1092-8464</identifier><identifier>EISSN: 1534-3189</identifier><identifier>DOI: 10.1007/s11936-000-0001-6</identifier><identifier>PMID: 20848356</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><ispartof>Current treatment options in cardiovascular medicine, 2000-04, Vol.2 (2), p.1-3</ispartof><rights>Current Science Inc 2000.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1736-303ba2c8ac95d346f0214c16f6665cacb5e0f9f8dbefeed93dabf5557a1620d3</citedby><cites>FETCH-LOGICAL-c1736-303ba2c8ac95d346f0214c16f6665cacb5e0f9f8dbefeed93dabf5557a1620d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2920182169?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,21369,27903,27904,33723,33724,43784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20848356$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spencer, A P</creatorcontrib><title>Vitamin E: cautionary issues</title><title>Current treatment options in cardiovascular medicine</title><addtitle>Curr Treat Options Cardiovasc Med</addtitle><description>Compared with many medications used in the patient with cardiovascular disease, vitamin E is a relatively safe supplement. There are a few populations in which caution needs to be employed, however. Patients receiving warfarin therapy should be discouraged from using vitamin E supplements and should be closely monitored if they do. Smokers should avoid vitamin E due to potential negative effects on vitamin C, and vitamin E should never be administered in conjunction with beta-carotene in this population. The rare patient requiring vitamin A therapy or having retinitis pigmentosa should also avoid vitamin E supplementation. Because of the increased risk of bleeding, vitamin E should be discontinued in the perioperative period in any patient requiring surgery.</description><issn>1092-8464</issn><issn>1534-3189</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdUEtLxDAQDqK46-oPEEQKHjxVZ5ImTbzJsj5gwcviNaRpAl36WJv24L83pasHD8PM4XvM9xFyjfCAAPljQFRMpAAwDabihCyRsyxlKNVpvEHRVGYiW5CLEPYAlDMpz8mCgswk42JJbj6rwTRVm2yeEmvGoepa038nVQijC5fkzJs6uKvjXpHdy2a3fku3H6_v6-dtajGP_gxYYaiVxipeskx4oJhZFF4Iwa2xBXfglZdl4bxzpWKlKTznPDcoKJRsRe5n2UPffUXbQTdVsK6uTeu6Meic85gHECPy7h9y3419G3_TVFFASVGoiMIZZfsuhN55feirJsbSCHoqTs_F6VjaNKhF5NwelceiceUf47cp9gOsCGZx</recordid><startdate>200004</startdate><enddate>200004</enddate><creator>Spencer, A P</creator><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>200004</creationdate><title>Vitamin E: cautionary issues</title><author>Spencer, A P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1736-303ba2c8ac95d346f0214c16f6665cacb5e0f9f8dbefeed93dabf5557a1620d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spencer, A P</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Current treatment options in cardiovascular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spencer, A P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vitamin E: cautionary issues</atitle><jtitle>Current treatment options in cardiovascular medicine</jtitle><addtitle>Curr Treat Options Cardiovasc Med</addtitle><date>2000-04</date><risdate>2000</risdate><volume>2</volume><issue>2</issue><spage>1</spage><epage>3</epage><pages>1-3</pages><issn>1092-8464</issn><eissn>1534-3189</eissn><abstract>Compared with many medications used in the patient with cardiovascular disease, vitamin E is a relatively safe supplement. There are a few populations in which caution needs to be employed, however. Patients receiving warfarin therapy should be discouraged from using vitamin E supplements and should be closely monitored if they do. Smokers should avoid vitamin E due to potential negative effects on vitamin C, and vitamin E should never be administered in conjunction with beta-carotene in this population. The rare patient requiring vitamin A therapy or having retinitis pigmentosa should also avoid vitamin E supplementation. Because of the increased risk of bleeding, vitamin E should be discontinued in the perioperative period in any patient requiring surgery.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>20848356</pmid><doi>10.1007/s11936-000-0001-6</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1092-8464
ispartof Current treatment options in cardiovascular medicine, 2000-04, Vol.2 (2), p.1-3
issn 1092-8464
1534-3189
language eng
recordid cdi_proquest_miscellaneous_755189011
source Springer Nature - Complete Springer Journals; ProQuest Central
title Vitamin E: cautionary issues
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T11%3A44%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vitamin%20E:%20cautionary%20issues&rft.jtitle=Current%20treatment%20options%20in%20cardiovascular%20medicine&rft.au=Spencer,%20A%20P&rft.date=2000-04&rft.volume=2&rft.issue=2&rft.spage=1&rft.epage=3&rft.pages=1-3&rft.issn=1092-8464&rft.eissn=1534-3189&rft_id=info:doi/10.1007/s11936-000-0001-6&rft_dat=%3Cproquest_cross%3E2920182169%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2920182169&rft_id=info:pmid/20848356&rfr_iscdi=true